Rockwell Medical and Innovative Renal Care sign three-year partnership agreement

Rockwell Medical (RMTI) and Innovative Renal Care, or IRC, one of the largest dialysis service providers in the U.S., signed a multi-year service agreement to support IRC’s goals to invest in high-quality hemodialysis products, streamline workflows, and help avoid potential supply chain disruptions. Under the terms of the agreement, Rockwell Medical will supply IRC with liquid and dry, acid and bicarbonate hemodialysis concentrates, as well as the DAMX45 dry acid concentrate mix system, which is 510(k) approved to be used exclusively with Rockwell Medical’s CitraPure and Dri-Sate dry acid concentrate powders. This will enable IRC’s dialysis centers across the U:S. to reduce storage requirements while ensuring product quality and continuity. This multi-million dollar purchase agreement with utilization commitments will remain in effect for three years with the option to extend an additional one-year period.